Morten O Jensen

Morten O Jensen


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2013 in Circulation
Verified
Journal Article
Open access
PDF file
MJMorten O Jensen
Morten O Jensen
AHAlbert Hagege
Albert Hagege
YOYutaka Otsuji
Yutaka Otsuji
RLrobert a levine
robert a levine

15 September 2009 in Circulation
Verified
Journal Article
Open access
PDF file
HJHenrik Jensen
Henrik Jensen
MJMorten O Jensen
Morten O Jensen
MSMorten H. Smerup
Morten H. Smerup
SVStefan Vind-Kezunovic
Stefan Vind-Kezunovic
SRSteffen Ringgaard
Steffen Ringgaard
SNSten L. Nielsen
Sten L. Nielsen
Background— The optimal surgical treatment in functional ischemic mitral regurgitation (FIMR) remains controversial. Recently, a posterior papillary muscle relocation (PMR) technique as adjunct procedure to ring annuloplasty has been proposed to prevent recurrent FIMR. In the present study, we used 3D cardiac MRI to assess the impact of relocating both papillary muscles as adjunct procedure to downsized ring annuloplasty on mitral leaflet coaptation geometry in FIMR pigs. Methods and Results— Eleven FIMR pigs were randomized to downsized ring annuloplasty (RA; n=6) or RA combined with PMR (RA+PMR, n=5). In the RA+PMR group, a 2–0 Gore-Tex suture was attached to each trigone, exteriorized through the corresponding papillary muscle, mounted on an epicardial pad, and tightened to relocate the myocardium adjacent to the anterior and posterior papillary muscles 5 and 15 mm, respectively. Using 3D MRI, the impact from these interventions on leaflet geometry was assessed. The distance from the posterior papillary muscle to the anterior trigone was reduced significantly more (median values) in the RA+PMR compared with RA animals at end-diastole (−7.9% versus 3.8%, P <0.01) and end-systole (−9.7% versus 2.5%, P =0.02). Accordingly, lateral tethering of the coaptation point (median values) was reduced significantly more in RA+PMR compared with RA animals (−42.8% versus −29.1%, P <0.01). Conclusions— Adding papillary muscle relocation to downsized ring annuloplasty reduced lateral leaflet tethering in a porcine experimental model of FIMR. Therefore, this technique holds promise for reducing persistent and recurrent FIMR in patients.

2 June 2021 in Cardiovascular Engineering and Technology
Verified
Journal Article
Open access
PDF file
MLMegan E. Laughlin
Megan E. Laughlin
SSSam Stephens
Sam Stephens
JHJamie A. Hestekin
Jamie A. Hestekin
MJMorten O Jensen
Morten O Jensen
Purpose: Flow phantoms are used in experimental settings to aid in the simulation of blood flow. Custom geometries are available, but current phantom materials present issues with degradability and/or mimicking the mechanical properties of human tissue. In this study, a method of fabricating custom wall-less flow phantoms from a tissue-mimicking gel using 3D printed inserts is developed. Methods: A 3D blood vessel geometry example of a bifurcated artery model was 3D printed in polyvinyl alcohol, embedded in tissue-mimicking gel, and subsequently dissolved to create a phantom. Uniaxial compression testing was performed to determine the Young’s moduli of the five gel types. Angle-independent, ultrasound-based imaging modalities, Vector Flow Imaging (VFI) and Blood Speckle Imaging (BSI), were utilized for flow visualization of a straight channel phantom. Results: A wall-less phantom of the bifurcated artery was fabricated with minimal bubbles and continuous flow demonstrated. Additionally, flow was visualized through a straight channel phantom by VFI and BSI. The available gel types are suitable for mimicking a variety of tissue types, including cardiac tissue and blood vessels. Conclusion: Custom, tissue-mimicking flow phantoms can be fabricated using the developed methodology and have potential for use in a variety of applications, including ultrasound-based imaging methods. This is the first reported use of BSI with an in vitro flow phantom.

30 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSam Stephens
Sam Stephens
SLSerguei Liachenko
Serguei Liachenko
NINeil B Ingels
Neil B Ingels
JWJonathan F Wenk
Jonathan F Wenk
MJMorten O Jensen
Morten O Jensen
Imaging techniques of the mitral valve have improved tremendously during the last decade, but challenges persist. The delicate changes in annulus shape and papillary muscle position throughout the cardiac cycle have significant impact on the stress distribution in the leaflets and chords, thus preservation of anatomically accurate positioning is critical. The aim of this study was to develop an in vitro method and apparatus for obtaining high-resolution 3D MRI images of porcine mitral valves in both the diastolic and systolic configurations with physiologically appropriate annular shape, papillary muscle positions and orientations, specific to the heart from which the valve was harvested. Positioning and mounting was achieved through novel, customized mounting hardware consisting of papillary muscle and annulus holders with geometries determined via pre-mortem ultrasonic intra-valve measurements. A semi-automatic process was developed and employed to tailor Computer Aided Design models of the holders used to mount the valve. All valve mounting hardware was 3D printed using a stereolithographic printer, and the material of all fasteners used were brass for MRI compatibility. The mounted valves were placed within a clear acrylic case, capable of holding a zero-pressure and pressurized liquid bath of a MRI-compatible fluid. Obtaining images from the valve submerged in liquid fluid mimics the natural environment surrounding the valve, avoiding artefacts due to tissue surface tension mismatch and gravitational impact on tissue shape when not neutrally buoyant. Fluid pressure was supplied by reservoirs held at differing elevations and monitored and controlled to within ±1mmHg to ensure that the valves remained steady. The valves were scanned in a 7 Tesla MRI system providing a voxel resolution of at least 80μm. The systematic approach produced 3D datasets of high quality which, when combined with physiologically accurate positioning by the apparatus, can serve as an important input for validated computational models.

1 September 2015 in Journal of Medical Devices
Verified
Journal Article
Closed access
PDF file
ADAndrew Drach
Andrew Drach
AKAmir H. Khalighi
Amir H. Khalighi
FHFleur M. ter Huurne
Fleur M. ter Huurne
Chung-Hao LeeChung-Hao Lee
Chung-Hao Lee
CBCharles Bloodworth
Charles Bloodworth
MSMichael Sacks
Michael Sacks

3 August 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Kayla WoodKayla Wood
Kayla Wood
SSSam Stephens
Sam Stephens
FXFeng Xu
Feng Xu
AHAlshaimaa Hazaa
Alshaimaa Hazaa
JMJames C. Meek
James C. Meek
SWSumith Ranil Wickramasinghe
Sumith Ranil Wickramasinghe
Strokes are among the leading causes of death worldwide. Ischemic stroke, due to plaque or other buildup blocking blood flow to the brain, is the most common type. Although ischemic stroke is treatable, current methods have severe shortcomings with high mortality rates. Clot retrieval devices, for example, can result in physically damaged vessels and death. This study aims to create blood clots that are representative of those found in vivo and demonstrate a new method of removing them. Static blood clots were formed using a 9:1 ratio of whole sheep blood and 2.45% calcium chloride solution. This mixture was heated in a water bath at 37 °C for approximately one hour until solidified. Following clot solidification, human plasmin was introduced by various methods, including soaking, injection, and membrane perfusion, and the resulting dissolution percentages were determined. Different clot types, representative of the wide range found physiologically, were also manufactured and their dissolution characteristics evaluated. A method to reproducibly create blood clots, characteristic of those found in vivo, is essential for the production of stroke retrieval devices that can efficiently and effectively remove clots from patients with low mortality rates and little/no damage to the surrounding vessels.